Case Study

Crystallization Process Development: Ramping Up Bench-Scale Control For Manufacturing

Source: Cambrex

By Hayley Reece, Executive Director, Technical Services, and Craig Callahan, PhD, Project Scientist 4, Crystallization Process Development, Cambrex

GettyImages-1320388413-crystallization-crystal

Crystallization is an essential element of drug development, whether it is performed during formation of an API or as a means to purify intermediates. Since physical structure and biological activity are directly linked, controlling the physical form of a compound is paramount to a final drug product’s quality and effectiveness. Drug manufacturers must also demonstrate to regulatory authorities that the physical properties and chemical purity of a drug substance are well understood and controlled. Therefore, the development of a robust crystallization process is an integral part of drug development.

Before scientists can manipulate various critical process parameters to yield the optimal result, they must have an in-depth understanding of the thermodynamic and kinetic processes affecting the product material. At Cambrex, we leverage our expertise to bridge the gap between the bench and manufacturing, providing controlled crystallization processes to help our clients achieve clinical delivery timelines.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Drug Discovery Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: